Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0JN8Q
|
||||
Former ID |
DNC005913
|
||||
Drug Name |
N-benzoyl-phenylalanyl-glycine-nitrile
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527885] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H17N3O2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CC(C(=O)NCC#N)NC(=O)C2=CC=CC=C2
|
||||
InChI |
1S/C18H17N3O2/c19-11-12-20-18(23)16(13-14-7-3-1-4-8-14)21-17(22)15-9-5-2-6-10-15/h1-10,16H,12-13H2,(H,20,23)(H,21,22)/t16-/m0/s1
|
||||
InChIKey |
WEIUVZVWLANUJJ-INIZCTEOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | Inhibitor | [527885] | |
Cathepsin S | Target Info | Inhibitor | [527885] | ||
Cathepsin K | Target Info | Inhibitor | [527885] | ||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
Activation of Matrix Metalloproteinases | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.